174 related articles for article (PubMed ID: 22406361)
21. MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers.
Proca DM; Niemann TH; Porcell AI; DeYoung BR
Appl Immunohistochem Mol Morphol; 2000 Jun; 8(2):120-5. PubMed ID: 10937059
[TBL] [Abstract][Full Text] [Related]
22. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
23. The utility of villin and mammaglobin in the differential diagnosis between intrahepatic cholangiocarcinoma and breast cancer.
Yang Z
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):19-25. PubMed ID: 25153498
[TBL] [Abstract][Full Text] [Related]
24. S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy.
Levy M; Lin F; Xu H; Dhall D; Spaulding BO; Wang HL
Hum Pathol; 2010 Sep; 41(9):1210-9. PubMed ID: 20382408
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver.
Hornick JL; Lauwers GY; Odze RD
Am J Surg Pathol; 2005 Mar; 29(3):381-9. PubMed ID: 15725808
[TBL] [Abstract][Full Text] [Related]
26. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.
Gandou C; Harada K; Sato Y; Igarashi S; Sasaki M; Ikeda H; Nakanuma Y
Hum Pathol; 2013 May; 44(5):811-21. PubMed ID: 23134772
[TBL] [Abstract][Full Text] [Related]
27. Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas.
Hong SM; Li A; Olino K; Wolfgang CL; Herman JM; Schulick RD; Iacobuzio-Donahue C; Hruban RH; Goggins M
Mod Pathol; 2011 Sep; 24(9):1237-47. PubMed ID: 21552209
[TBL] [Abstract][Full Text] [Related]
28. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.
Koopmann J; Buckhaults P; Brown DA; Zahurak ML; Sato N; Fukushima N; Sokoll LJ; Chan DW; Yeo CJ; Hruban RH; Breit SN; Kinzler KW; Vogelstein B; Goggins M
Clin Cancer Res; 2004 Apr; 10(7):2386-92. PubMed ID: 15073115
[TBL] [Abstract][Full Text] [Related]
29. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.
Collins AL; Wojcik S; Liu J; Frankel WL; Alder H; Yu L; Schmittgen TD; Croce CM; Bloomston M
Ann Surg Oncol; 2014 Jan; 21(1):133-8. PubMed ID: 24046106
[TBL] [Abstract][Full Text] [Related]
30. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
[TBL] [Abstract][Full Text] [Related]
31. Synchronous pancreatic adenocarcinoma and intrahepatic cholangiocarcinoma arising in the context of intraductal papillary neoplasms.
Bansal A; Thung SN; Zhu H; Schwartz M; Lewis S
Clin Imaging; 2016; 40(5):897-901. PubMed ID: 27183137
[TBL] [Abstract][Full Text] [Related]
32. Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary.
Isidro RA; Abukhiran I; Dunseth CD; Gosse MD; Humble RM; Pelletier DJ; Varshney N; Bellizzi AM; Hornick JL
Am J Surg Pathol; 2023 Apr; 47(4):440-452. PubMed ID: 36730833
[TBL] [Abstract][Full Text] [Related]
33. Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis.
Takenami T; Maeda S; Karasawa H; Suzuki T; Furukawa T; Morikawa T; Takadate T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Unno M
BMC Cancer; 2019 Apr; 19(1):318. PubMed ID: 30953499
[TBL] [Abstract][Full Text] [Related]
34. Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts.
Ney JT; Zhou H; Sipos B; Büttner R; Chen X; Klöppel G; Gütgemann I
Hum Pathol; 2007 Feb; 38(2):359-64. PubMed ID: 17137615
[TBL] [Abstract][Full Text] [Related]
35. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.
Swierczynski SL; Maitra A; Abraham SC; Iacobuzio-Donahue CA; Ashfaq R; Cameron JL; Schulick RD; Yeo CJ; Rahman A; Hinkle DA; Hruban RH; Argani P
Hum Pathol; 2004 Mar; 35(3):357-66. PubMed ID: 15017593
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic ductal adenocarcinoma and distal cholangiocarcinoma: a proposal of preoperative diagnostic score for differential diagnosis.
Muttillo EM; Ciardi A; Troiano R; Saullo P; Masselli G; Guida M; Tortora A; Sperduti I; Marinello G; Chirletti P; Caronna R
World J Surg Oncol; 2021 Jan; 19(1):10. PubMed ID: 33430887
[TBL] [Abstract][Full Text] [Related]
37. Infiltration of peritumoural but tumour-free parenchyma with IgG4-positive plasma cells in hilar cholangiocarcinoma and pancreatic adenocarcinoma.
Resheq YJ; Quaas A; von Renteln D; Schramm C; Lohse AW; Lüth S
Dig Liver Dis; 2013 Oct; 45(10):859-65. PubMed ID: 23602806
[TBL] [Abstract][Full Text] [Related]
38. Zonula occludens-1, occludin, and E-cadherin protein expression in biliary tract cancers.
Németh Z; Szász AM; Somorácz A; Tátrai P; Németh J; Gyorffy H; Szíjártó A; Kupcsulik P; Kiss A; Schaff Z
Pathol Oncol Res; 2009 Sep; 15(3):533-9. PubMed ID: 19184677
[TBL] [Abstract][Full Text] [Related]
39. Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity.
Schmuck RB; de Carvalho-Fischer CV; Neumann C; Pratschke J; Bahra M
Cancer Med; 2016 Jan; 5(1):88-99. PubMed ID: 26645826
[TBL] [Abstract][Full Text] [Related]
40. Lipid profiles for intrahepatic cholangiocarcinoma identified using matrix-assisted laser desorption/ionization mass spectrometry.
Park YS; Yoo CW; Lee SC; Park SJ; Oh JH; Yoo BC; Paik SS; Lee KG; Jin SY; Kim SC; Kim KP; Kim YH; Choi D; Kim HK
Clin Chim Acta; 2011 Oct; 412(21-22):1978-82. PubMed ID: 21777572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
